Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches
Background: Activated Cdc42-associated kinase (ACK1) is essential for numerous cellular functions, such as growth, proliferation, and migration. ACK1 signaling occurs through multiple receptor tyrosine kinases; therefore, its inhibition can provide effective antiproliferative effects against multipl...
Main Authors: | Vikas Kumar, Raj Kumar, Shraddha Parate, Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/2/217 |
Similar Items
-
Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations
by: Vikas Kumar, et al.
Published: (2021-09-01) -
Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics
by: Shraddha Parate, et al.
Published: (2021-05-01) -
Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods
by: Apoorva M. Kulkarni, et al.
Published: (2022-01-01) -
3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors
by: Vikas Kumar, et al.
Published: (2022-06-01) -
Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
by: Shraddha Parate, et al.
Published: (2021-03-01)